HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Davis, J. C. Articles by Khan, K. Search for Related Content PubMed PubMed Citation Articles by Davis, J. C. Articles by Khan, K.

HipWatch: Osteoporosis Investigation and Treatment After a Hip Fracture: A 6-Month Randomized Controlled Trial

¹ University of British Columbia Center for Hip Health, Vancouver, Canada.
² Vancouver Coastal Health Research Institute, Canada.
Departments of ³ HealthCare and Epidemiology, ⁴ Orthopaedics,⁵ Physical Therapy, and ⁶ Family Practice, University of British Columbia, Vancouver, Canada.

Address correspondence to Karim Khan, MD, PhD, University of British Columbia, Center for Hip Health, David Strangway Building, Suite 320-5950 University Boulevard, Vancouver, BC, Canada V6T 1Z3. E-mail: karim.khan{at}ubc.ca

Objective. We aimed to determine whether a novel Patient Empowerment and Physician Alerting (PEPA) intervention would improve the proportion of seniors who were investigated and treated for osteoporosis after hip fracture.

Methods. We undertook a 6-month randomized controlled trial (RCT) in 48 women and men 60 years old who had suffered a hip fracture and were admitted to a tertiary-care university hospital. The primary outcome measure was the proportion of participants offered one or more osteoporosis-specific ‘best practices' measured using the Diagnosis and Management Questionnaire (DMQ). Participant responses were validated in part by physician report.

Results. In the PEPA intervention group, 19 (68%) were offered one or more components of best practice care compared with 7 (35%) in the ‘usual care’ group (p <.05). In the PEPA group, 15 (54%) (p <.01) were prescribed bisphosphonate therapy, 8 (29%) (p <.01) had a bone mineral density scan, 11 (39%) were prescribed calcium and vitamin D (p =.32), and 9 (32%) (p <.01) were prescribed exercise. In the usual care group, 0 (0%) were prescribed bisphosphonate therapy, a bone mineral density assessment, or exercise and 6 (30%) were prescribed calcium and vitamin D.

Conclusions. This simple, inexpensive PEPA intervention resulted in far superior clinical management than did usual care in a population at high risk of future hip fracture.